Agilent Technologies Inc. reported net revenue of USD 7.0 billion for the full year ended October 31, 2025, marking a 7 percent increase. Growth was driven across all segments, geographic regions, and most key end markets. Product revenue rose 6 percent, primarily supported by increases in contract development and manufacturing. The Agilent CrossLab segment posted revenue of USD 2.9 billion, up 6 percent for the period, with growth attributed to strength in repair, maintenance, compliance services, lab automation, and consumables. Revenue from the BIOVECTRA acquisition contributed approximately 2 percentage points to overall revenue growth for the year. The company previously registered a 5 percent year-over-year decline in net revenue for the full year ended October 31, 2024. Foreign currency movements had no impact on revenue growth for the year ended October 31, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agilent Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001090872-25-000087), on December 22, 2025, and is solely responsible for the information contained therein.
Comments